醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
BBIO · BridgeBio Pharma, Inc.
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
BridgeBio Pharma, Inc.（BBIO）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $19.2M；高管董事有效買入 —、有效賣出 —。最近申報 2026-09-21。
買入 Bought—
賣出 Sold$19.2M
有效買入 Effective bought—
有效賣出 Effective sold—
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-09-17 | Kumar Neil Chief Executive Officer, Director | 賣出 Sell | 10,000 | $69.08 | $691K | SEC |
| 2026-08-18 | Kumar Neil Chief Executive Officer, Director | 賣出 Sell | 44,980 | $82.86 | $3.7M | SEC |
| 2026-07-30 | Apuli Maricel Chief Accounting Officer | 賣出 Sell | 2,000 | $80.06 | $160K | SEC |
| 2026-07-09 | Cook Jennifer E. Director | 賣出 Sell | 148,589 | $88.54 | $13.2M | SEC |
| 2026-07-09 | Ellis Andrea Director | 賣出 Sell | 17,167 | $84.00 | $1.4M | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-08-19 | Kumar Neil Director, Officer | 30,000 | $2.5M | 10b5-1 |
| 2026-08-18 | Kumar Neil Director, Officer | 34,980 | $2.8M | 10b5-1 |
| 2026-08-17 | Scott Randal W. Director | 21,501 | $1.7M | 10b5-1 |
| 2026-07-09 | Cook Jennifer E. Director | 148,589 | $13.2M | 10b5-1 |
| 2026-07-09 | Ellis Andrea Director | 17,167 | $1.4M | 10b5-1 |
內部人 Insiders
Kumar Neil、Apuli Maricel、Cook Jennifer E.、Ellis Andrea